In terms of elective esthetic services, the use of Botulinum Toxin (Botox® and Dysport®) and dermal fillers, such as Juvederm® Ultra and Restylane are up 9 and 10% respectively over last year. That is a very significant increase, especially since the use of these minimally invasive elective esthetic treatments kept rising through the recession.
There are a couple of reasons why this may be happening. First, people want to look better but the investment for face lifts or ten porcelain veneers may be out of their financial realm right now. They want to do something to look better, even if it is a temporary treatment. The second reason is that clinicians who are performing facial esthetic treatment are learning new techniques and receiving better continuing education which helps many clinicians achieve better results that last longer.
Check out our seminar schedule as we will be offering more Level I and Level II courses across the country. A brand new Level III course will be available in the first quarter of 2012. So watch for that soon.
By Arianna Bankovich, RN Introduction: Botox, derived from the bacterium Clostridium botulinum, has long been renowned for its cosmetic applications in reducing wrinkles and fine
By Crystal Wilson, CNP In the dynamic landscape of healthcare, career trajectories often take unexpected turns. One noticeable trend in recent years is the increasing
By Katie Barrer, RDH Who better suited to treat their patients for bruxism than dental hygienists? Two states allow RDHs to administer Botox for